Blue Jet Healthcare Limited
BLUEJET.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$89.16B
Close$
$100.73
80.4% downside
Current Fair Value
80.4% downsideOvervalued by 80.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $89.16 Billion |
|---|---|
| Enterprise Value | $89.16 Billion |
| Dividend Yield | $1.20 (0.23%) |
| Earnings per Share | $14.29 |
| Beta | 0.64 |
| Outstanding Shares | 173,465,425 |
Return
| Return on Equity | 17.27% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 37.93 |
|---|---|
| PEG | -267.97 |
| Price to Sales | 10.08 |
| Price to Book Ratio | 6.59 |
| Enterprise Value to Revenue | 10.07 |
| Enterprise Value to EBIT | 32.97 |
| Enterprise Value to Net Income | 37 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
$4.23
Average shareholder expectationRevenue Estimate
$3.01 B
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$4.37
Average shareholder expectationRevenue Estimate
$2.84 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Blue Jet Healthcare Limited
581 employees
CEO: Shiven Arora Established in 1968 and based in Thane, India, Blue Jet Healthcare Limited is a key player in the pharmaceutical sector. The company primarily focuses on the manufacturing and sale of specialized chemical intermediates and active pharmac...